Safety and Efficacy of Bleb Needling with Antimetabolite after Trabeculectomy Failure in Glaucoma Patients: A Systemic Review and Meta-Analysis
Open Access
- 27 November 2020
- journal article
- review article
- Published by Wiley in Journal of Ophthalmology
- Vol. 2020, 1-13
Abstract
Safety and Efficacy of Bleb Needling with Antimetabolite after Trabeculectomy Failure in Glaucoma Patients: A Systemic Review and Meta-Analysis: Background. Bleb needling with subconjunctival injection of antimetabolites had become a widely accepted approach for trabeculectomy failure. However, IOP reduction effects, success rates, and complications occurrence for this procedure showed great inconsistency among the different studies. Methods. We conducted a literature search on PubMed, Embase, Cochrane Library, and ClinicalTrials.gov. A random-effects model was performed on the extracted data based on the included studies. The intraocular pressure (IOP) and number of antiglaucomatous medications before and after the surgery were pooled for meta-analysis. The success and complication rates were estimated based on the results. Subgroup analysis, sensitivity analysis, and metaregression were applied to explore the origination of heterogeneity. Results. Thirty-seven studies with a total of 2182 patients were finally included in our review. For the present meta-analysis, the overall effects of bleb needling at the last visit revealed a reduction in IOP of 9.74 mmHg (95% confidence interval (CI) [8.85, 10.63]), 45.9% (95% CI [39.0%, 53.0%]) for complete success rate, and 70.4% (95% CI [63.5%, 77.0%]) for qualified success rate. Application of mitomycin C (MMC) and 5-fluorouracil (5-Fu) during the procedure were efficacious for IOP control during the follow-up. Metaregression revealed that possible origination of heterogeneity was baseline IOP before bleb needling, revealing a trend that higher baseline IOP correlated with a greater IOP reduction results . For safety profile, conjunctival haemorrhage (5.7%, 95% CI [2.5%, 10.1%]), hyphema (5.5%, 95% CI [3.0%, 8.7%]), and bleb leakage (5.0%, 95% CI [3.2%, 7.3%]) had the highest estimate of incidence. An increasing number of needling was the main risk factor for needling failure. Conclusion. Bleb needling with antimetabolites could be considered an effective and safe procedure after trabeculectomy failure. After the process, patients will gain IOP control and reduce antiglaucomatous medications for at least six months with 5-Fu or MMC. Meanwhile, the overall estimates for complications were relatively low in the whole process.Keywords
Funding Information
- Capital’s Funds for Health Improvement and Research (CFH-2020-2-40911)
This publication has 43 references indexed in Scilit:
- Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective studyClinics, 2013
- Office-based slit-lamp needle revision with adjunctive Mitomycin-C for late failed or encapsulated filtering blebsMiddle East African Journal of Ophthalmology, 2012
- Mitomycin-C needle bleb revision in congenital glaucomaMiddle East African Journal of Ophthalmology, 2010
- Long-term Outcomes of Needle Revision of Trabeculectomy Blebs With Mitomycin C and 5-FluorouracilJournal of Glaucoma, 2009
- The Efficacy of 5-Fluorouracil Bleb Needling Performed 1 Year or More PosttrabeculectomyJournal of Glaucoma, 2009
- Needling Revision of TrabeculectomiesOphthalmology, 2008
- Prospective Evaluation of Preoperative Factors Associated With Successful Mitomycin C Needling of Failed Filtration BlebsJournal of Glaucoma, 2006
- Operative revision of non-functioning filtering blebs with 5-fluorouracil to regain intraocular pressure controlClinical & Experimental Ophthalmology, 2004
- Needling for encapsulated trabeculectomy filtering blebs2002
- Antimetabolite Use in Revising Failing Filtering BlebsSeminars in Ophthalmology, 1999